SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-020539
Filing Date
2023-02-14
Accepted
2023-02-14 06:53:46
Documents
5
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232109-1_def14a.htm DEF 14A 1128832
2 GRAPHIC tm232109-1_proxycard01.jpg GRAPHIC 328515
3 GRAPHIC tm232109-1_proxycard02.jpg GRAPHIC 144759
4 GRAPHIC tm234270d2_f4img001.jpg GRAPHIC 3855
5 GRAPHIC tm234270d2_f4sp4img001.jpg GRAPHIC 25342
  Complete submission text file 0001104659-23-020539.txt   1822548
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 23622176
SIC: 2836 Biological Products, (No Diagnostic Substances)